Health Care/Hospital

Kind Pharmaceuticals Announces Settlement

HANGZHOU, China, April 16, 2024 /PRNewswire/ -- Today, Hangzhou Andao Pharmaceutical Ltd. and Kind Pharmaceuticals LLC ("Kind Pharmaceuticals"), together with its Chief Executive Officer Dr.Dong Liu and Chief Scientific Officer Dr.Shaojiang Deng, announced a resolution of their recent dispute wit...

2024-04-17 00:17 585

Mabwell Releases Preclinical Study Results of Multiple Innovative Drugs Released at the 2024 AACR Annual Meeting

SHANGHAI, April 16, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, presented the preclinical research findings of three potential novel drug candidates in poster format at the American Association for Cancer Research (AACR) An...

2024-04-16 22:00 677

NUH LAUNCHES NEW DIGESTIVE CENTRE TO PUSH NEW FRONTIERS IN EARLY CANCER DETECTION AND CARE EXCELLENCE

The new National University Centre for Digestive Health aims to strengthen patient access to cutting-edge diagnostic technologies and innovations in early detection and quality specialised care SINGAPORE, April 16, 2024 /PRNewswire/ -- The National University Hospital (NUH) is embarking on a maj...

2024-04-16 21:00 710

IMG Sends Employees on Fifth Corporate Service Trip with School the World

INDIANAPOLIS, April 16, 2024 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is excited to highlight the success of its 2024 corporate service trip with School the World, a nonprofit organization focused on providing a...

2024-04-16 21:00 607

CSafe Elevates Cell and Gene Therapy Transport with Reusable Cryogenic Solution

MONROE, Ohio, April 16, 2024 /PRNewswire/ -- CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of a new line of cryogenic multi-use dewars for the cell and gene therapy market. The progressive technolog...

2024-04-16 20:47 625

YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024

GAITHERSBURG, Md., April 16, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...

2024-04-16 20:00 591

CryptoLab Signs a Contract to Supply Cutting-Edge Homomorphic Encryption Technology to Macrogen

SEOUL, South Korea, April 16, 2024 /PRNewswire/ -- CryptoLab, a pioneer of fully homomorphic encryption (FHE) technology has announced the signing of a three-year supply contract with Macrogen, Korea's largest genetic data analysis company. This landmark agreement was a huge milestone of FHE tech...

2024-04-16 20:00 501

Exploring Pioneering Programs in Medical Integration in the Greater Bay Area: Actively Applying Digital Identity and Global Legal Entity Identifier (LEI)

HONG KONG, April 16, 2024 /PRNewswire/ -- With the rapid development in information technology, digital transformation has become a core driver in promoting the integration of various sectors in the Greater Bay Area (GBA). In the GBA, a pioneering program has been carried out to explore the poten...

2024-04-16 19:05 638

AUO Leads Micro LED Ecosystem Dream Team toward Unlocking New Advances in Diverse Field Applications

Cutting-Edge Technology Combined with Mass Production Capabilities to Create New Values across Verticals, from Smart Mobility to Retail and Healthcare HSINCHU, April 16, 2024 /PRNewswire/ -- Taiwan's display industry leads the world, continually integrating new and diverse applications into peopl...

2024-04-16 19:00 553

Wingderm® Shines Bright in the U.S.A., Continuously Expanding the Local Business Network

BALTIMORE, April 16, 2024 /PRNewswire/ -- Wingderm®, a medical aesthetic device service provider that offers comprehensive aesthetic solutions, recently concluded its successful participation in the AAD (American Academy of Dermatology) Annual Meeting in March and the ASLMS (American Society for ...

2024-04-16 17:22 565

Exyte acquires Kinetics Group to enhance global leadership in high-tech facility solutions

* Kinetics is a globally leading provider of installation services and equipment  * Company serves high-tech industries such as semiconductor, biopharma, and batteries  * 2,500 employees at more than 20 locations worldwide  * Exyte to enter technical facility management business  * Exyte...

2024-04-16 17:00 708

Fundiin Partners with Medpro to Launch BNPL at Over 200 Hospitals and Medical Centers

HO CHI MINH,  Vietnam, April 16, 2024 /PRNewswire/ -- On April 11, 2024, Fundiin and Medpro held a signing ceremony to celebrate their strategic partnership, marking the inaugural launch of a Buy Now Pay Later (BNPL) payment method at over 200 hospitals ...

2024-04-16 14:00 844

IHH Healthcare Selects Oracle Exadata Platform to Improve Operational Efficiency and Patient Outcomes

One of the world's largest integrated healthcare providers harnesses the power of cloud acrossSingapore and Malaysia to improve operational efficiency SINGAPORE, April 17, 2024 /PRNewswire/ -- Oracle CloudWorld Tour Singapore -- IHH Healthcare (IHH), a world-leading integrated healthcare provide...

2024-04-16 12:00 753

Value innovations address health concerns amid rising costs

AUCKLAND, New Zealand, April 16, 2024 /PRNewswire/ -- Four in 10 consumers worldwide find health and wellbeing nutritional products too expensive, with one-third of users saying that rising costs have made it hard to continue purchasing them. Despite feeling the pinch, health and wellbeing still...

2024-04-16 10:00 715

Innovent Announces the Appointment of Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer (CMO)

SAN FRANCISCO and SUZHOU, China, April 16, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dis...

2024-04-16 08:00 853

TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation

* FDA Fast Track designation granted for TLX101-CDx for glioma (brain cancer) imaging * Collaboration agreement announced for joint development and commercialisation with UCSF * PharmaLogic announced as commercial manufacturing and pharmacy distribution partner MELBOURNE, Australia, April 1...

2024-04-16 06:42 747

【C.S】Cordyceps Sunshine has extended its market footprint in the world's largest traditional Chinese herbal medicine market with the introduction of their Cinnamomum product line.

TAIPEI, April 16, 2024 /PRNewswire/ -- Cordyceps Sunshine Group【C.S】Group, having recently achieved a successful U.S. IPO, hosted the '2024 China International Biomedical Innovation Development Conference and Chinese Rare Medicinal Herbs Cinnamomum Industry Transformation and Upgrade Conference' ...

2024-04-16 06:00 940

Pre-clinical result of LP-005, a novel bi-functional complement antibody-fusion protein was unveiled by LongBio at WCN2024

BUENOS AIRES, Argentina, April 15, 2024 /PRNewswire/ -- LongBio Pharma (Suzhou) Co., Ltd. (referred to as "LongBio"), a leading biotech company dedicated to developing innovative protein treatments for nephrology, allergy, respiratory, hematology, ophthalmology, and other autoimmune and rare dise...

2024-04-16 02:00 778

89th CMEF in Shanghai Elevates Global Medical Device Trade to The Next Level

SHANGHAI, April 15, 2024 /PRNewswire/ -- The 89th edition of the China International Medical Equipment Fair (CMEF) witnessed an impressive turnout of over 200,000 attendees from more than 150 countries. Prominent companies in the industry seized the opportunity to sho...

2024-04-15 21:00 979

First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trial

Plus, Actinogen receives approval of its application for a UK Innovation Passport as part of the Innovative Licensing and Access Pathway (ILAP) for Xanamem in the treatment of Alzheimer's disease Enrolment in XanaCIDD phase 2a trial of cognitive impairment and depression has surpassed 90% SYDNE...

2024-04-15 20:30 859
12345 ... 805